Gaustadalléen 21, 0349 Oslo
Norway
Telephone +47 99252274
post@skannex.com, siri@skannex.com
Product Categories
03 Diagnostics
03.01 Clinical chemistry
03.01.14 Rapid tests - clinical chemistry
MEDICA 2017
Rapid tests - clinical chemistry
Human IVD
Drug of Abuse
2 Products
03 Diagnostics
03.01 Clinical chemistry
03.01.14 Rapid tests - clinical chemistry
03.01.14.01 Point of care - testing systems
MEDICA 2017
Point of care - testing systems
Human IVD
Drug of Abuse
2 Products
03 Diagnostics
03.02 Immunochemistry (Immunology)
03.02.15 Rapid tests - Immunochemistry
MEDICA 2017
Rapid tests - Immunochemistry
Human IVD
Drug of Abuse
2 Products
03 Diagnostics
03.05 Infectious Immunology
03.05.08 Rapid tests - Infectious immunology
MEDICA 2017
Rapid tests - Infectious immunology
Human IVD
Drug of Abuse
2 Products
ad: contact information
Company
Company details
Skannex is a Norwegian company founded in 2006. The company has developed sophisticated software for image recognition, capturing and analysis of bioassays. Skannex offers next generation solutions filling the industries need for affordable, rapid and automatic reader solution with focus on lateral flow assays.
Our SkanMulti software are CE marked.
A patent comprising significant parts of the core technology is granted in all relevant markets.
Skannex is also offering reader instruments. Our reader instruments enabled by our SkanMulti software is an attractive alternative to small & expensive test specific instruments and big hospital laboratory instruments. Skannex reader instruments are CE marked.
Skannex is a B2B company and we have customers successfully utilizing Skannex technology for automation of their rapid lateral flow assays in the agricultural, clinical diagnostics and drug of abuse markets. We are proud to see that more and more companies are benefiting from our unique technology.
In 2011 a subsidiary was opened close to Shanghai China. And in 2017 we opened our subsidiary in Gurgaon, India. Skannex is currently doing business in Europe, USA , China and India and plan to expand into new territories.
ad: contact information